23 Hrs
المصدر:
Chicago Tribune
_1777370193195_831968492.png&w=48&q=75){kind=small}
_1777370220974_847775619.png&w=48&q=75){kind=small}
Moderna-Merck therapy prevents melanoma relapse
A personalized vaccine created by Moderna and Merck reduced melanoma recurrence in a large late-stage trial. The development raises hope for a treatment that could extend survival for patients with this aggressive cancer.
articleDetails.fontSize.sizeحجم النص
تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي
comments.heading